Obi-1

Acquired Hemophilia A

Baxalta now part of ShirePhase 2/3Dormant

CCC

52/ 100

Provisional rating · Methodology v0.2

Rating breakdown

3 Active assets in the Acquired Hemophilia A cohort.

Asset / Sponsor	Phase	Rating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Peking Union Medical College Hospital	Phase 4	BB
Cyclophosphamide Peking Union Medical College Hospital	Phase 4	BB
DARATUMUMAB Institute of Hematology & Blood Diseases Hospital, China	Phase 4	BB
Tak-672 Takeda	Phase 2/3	B
Emicizumab University of Washington	Phase 2	B
Bortezomib Peking Union Medical College Hospital	Phase 2	CCC
Susoctocog Alfa Takeda		D

Obi-1 is also rated in:

hemophilia ADormant

CCC

Indicative ·

49 / 100

Order a full diligence report on this asset.

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.